ABLIVA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.196 SEK | -0.41% |
|
+2.19% | -20.16% |
| Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| 2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABLIVA AB | Bio Therapeutic Drugs | -0.41% | +2.19% | -20.16% | -8.41% | -85.29% | 22.67M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABLI Stock
- Charts Abliva AB
- Comparison Chart